Employers and consultants are demanding more than top-line ROI — they want proof of how interventions change outcomes.  

Join Quantum Health executive leaders for a first look at a powerful new AI-driven capability that connects key navigation moments to measurable clinical and financial impact. Our Real-Time Intercept® model now leverages GenAI to deliver insights that prove value more meaningfully — not just in claims, but in care journeys changed for the better. 

During the discussion you’ll learn: 

  • How to equip yourself with smarter, client-ready proof points that go beyond traditional ROI metrics. 
  • Effective ways to use member-level insights to drive strategic conversations and refine plan design. 
  • How responsible, closed-loop GenAI sets Quantum Health apart from competitors relying on automation alone. 

Panelists

Chris Reed photo
Chris Reed
Director of Value Creation
Quantum Health
Shannon Skaggs photo
Shannon Skaggs
Chief AI Officer
Quantum Health
Missy Jaeger photo
Missy Jaeger
Vice President of Consultant Relations
Quantum Health

More like this

woman meditating with headphones on
Webinar

Digital Mental Health Benefits: Beyond Access, Toward Impact

Providing access to mental health resources isn’t enough. To drive sustainable outcomes, employers need to guide employees toward the right support at the right time — and help them use those resources effectively. 

Learn more
Quantum Health and Progyny logos
Webinar

Beyond Fertility: Supporting Women's Health at Every Stage

Women’s and family health needs are evolving, and employers must rethink benefits strategies to provide inclusive, comprehensive support. Join industry experts for a conversation on creating equitable benefits that go beyond fertility treatment to improve access, outcomes and cost efficiency.

Learn more
Vida and Quantum Health logo
Webinar

Managing GLP-1 Costs Without Compromising Outcomes

GLP-1 medications continue to surge in popularity, offering effective solutions for weight management, Type 2 diabetes, and other emerging indications. While these drugs show significant clinical benefits, their skyrocketing costs present a major challenge for self-insured employers. Current solutions fall short at addressing the core issue: ensuring members have access to these medications when appropriate while supporting long-term health and sustainable cost management.

Learn more